144 related articles for article (PubMed ID: 30409303)
1. Label-free tissue proteomics can classify oral squamous cell carcinoma from healthy tissue in a stage-specific manner.
Dickinson A; Saraswat M; Mäkitie A; Silén R; Hagström J; Haglund C; Joenväärä S; Silén S
Oral Oncol; 2018 Nov; 86():206-215. PubMed ID: 30409303
[TBL] [Abstract][Full Text] [Related]
2. Oral squamous cell carcinoma patients can be differentiated from healthy individuals with label-free serum proteomics.
Saraswat M; Mäkitie A; Agarwal R; Joenväärä S; Renkonen S
Br J Cancer; 2017 Jul; 117(3):376-384. PubMed ID: 28632724
[TBL] [Abstract][Full Text] [Related]
3. Significance of PD-L1 Expression in Tongue Cancer Development.
Yoshida S; Nagatsuka H; Nakano K; Kogashiwa Y; Ebihara Y; Yano M; Yasuda M
Int J Med Sci; 2018; 15(14):1723-1730. PubMed ID: 30588196
[No Abstract] [Full Text] [Related]
4. Salivary proteins from dysplastic leukoplakia and oral squamous cell carcinoma and their potential for early detection.
Sivadasan P; Gupta MK; Sathe G; Sudheendra HV; Sunny SP; Renu D; Hari PS; Gowda H; Suresh A; Kuriakose MA; Sirdeshmukh R
J Proteomics; 2020 Feb; 212():103574. PubMed ID: 31706945
[TBL] [Abstract][Full Text] [Related]
5. Label-free plasma proteomics for the identification of the putative biomarkers of oral squamous cell carcinoma.
Gautam SS; Singh RP; Karsauliya K; Sonker AK; Reddy PJ; Mehrotra D; Gupta S; Singh S; Kumar R; Singh SP
J Proteomics; 2022 May; 259():104541. PubMed ID: 35231661
[TBL] [Abstract][Full Text] [Related]
6. Quantitative Proteomic Analysis of Non-Tobacco Associated Oral Squamous Cell Carcinoma Reveals Deregulation of Cytoskeletal and Apoptotic Proteins.
T A S; Narayan M; Krishnan R; Thayalan D; Gunasekaran N; S P
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4285-4292. PubMed ID: 36580011
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of fluorescence visualization-guided surgery for early-stage tongue squamous cell carcinoma compared to iodine vital staining.
Ikeda Y; Suzuki T; Saitou H; Ogane S; Hashimoto K; Takano N; Nomura T
Int J Clin Oncol; 2020 Sep; 25(9):1604-1611. PubMed ID: 32451767
[TBL] [Abstract][Full Text] [Related]
8. Proteomics-based identification of haptoglobin as a novel plasma biomarker in oral squamous cell carcinoma.
Lai CH; Chang NW; Lin CF; Lin CD; Lin YJ; Wan L; Sheu JJ; Chen SY; Huang YP; Sing YT; Tao TW; Lai CK; Tsai MH; Chan HL; Jou YJ; Lin CW
Clin Chim Acta; 2010 Jul; 411(13-14):984-91. PubMed ID: 20359475
[TBL] [Abstract][Full Text] [Related]
9. Comparative proteomic analysis of oral squamous cell carcinoma and adjacent non-tumour tissue from Thailand.
Chanthammachat P; Promwikorn W; Pruegsanusak K; Roytrakul S; Srisomsap C; Chokchaichamnankit D; Svasti J; Boonyaphiphat P; K S; Thongsuksai P
Arch Oral Biol; 2013 Nov; 58(11):1677-85. PubMed ID: 24112734
[TBL] [Abstract][Full Text] [Related]
10. Proteomics-based identification of plasma biomarkers in oral squamous cell carcinoma.
Tung CL; Lin ST; Chou HC; Chen YW; Lin HC; Tung CL; Huang KJ; Chen YJ; Lee YR; Chan HL
J Pharm Biomed Anal; 2013 Mar; 75():7-17. PubMed ID: 23312379
[TBL] [Abstract][Full Text] [Related]
11. Identification of RAB2A and PRDX1 as the potential biomarkers for oral squamous cell carcinoma using mass spectrometry-based comparative proteomic approach.
Dey KK; Pal I; Bharti R; Dey G; Kumar BN; Rajput S; Parekh A; Parida S; Halder P; Kulavi I; Mandal M
Tumour Biol; 2015 Dec; 36(12):9829-37. PubMed ID: 26159854
[TBL] [Abstract][Full Text] [Related]
12. Potential Salivary Proteomic Markers of Oral Squamous Cell Carcinoma.
Gallo C; Ciavarella D; Santarelli A; Ranieri E; Colella G; Lo Muzio L; Lo Russo L
Cancer Genomics Proteomics; 2016; 13(1):55-61. PubMed ID: 26708599
[TBL] [Abstract][Full Text] [Related]
13. TRH site-specific methylation in oral and oropharyngeal squamous cell carcinoma.
Puttipanyalears C; Arayataweegool A; Chalertpet K; Rattanachayoto P; Mahattanasakul P; Tangjaturonsasme N; Kerekhanjanarong V; Mutirangura A; Kitkumthorn N
BMC Cancer; 2018 Aug; 18(1):786. PubMed ID: 30081853
[TBL] [Abstract][Full Text] [Related]
14. Potential Markers from Serum-Purified Exosomes for Detecting Oral Squamous Cell Carcinoma Metastasis.
Li C; Zhou Y; Liu J; Su X; Qin H; Huang S; Huang X; Zhou N
Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1668-1681. PubMed ID: 31350263
[TBL] [Abstract][Full Text] [Related]
15. Identification of GIMAP7 and Rabl3 as Putative Biomarkers for Oral Squamous Cell Carcinoma Through Comparative Proteomic Approach.
Usman M; Ilyas A; Hashim Z; Zarina S
Pathol Oncol Res; 2020 Jul; 26(3):1817-1822. PubMed ID: 31748878
[TBL] [Abstract][Full Text] [Related]
16. Tongue Cancer Patients Can be Distinguished from Healthy Controls by Specific N-Glycopeptides Found in Serum.
Saraswat M; Mäkitie A; Tohmola T; Dickinson A; Saraswat S; Joenväärä S; Renkonen S
Proteomics Clin Appl; 2018 Nov; 12(6):e1800061. PubMed ID: 29992770
[TBL] [Abstract][Full Text] [Related]
17. Predicting the Presence of Oral Squamous Cell Carcinoma Using Commonly Dysregulated MicroRNA in Oral Swirls.
Yap T; Koo K; Cheng L; Vella LJ; Hill AF; Reynolds E; Nastri A; Cirillo N; Seers C; McCullough M
Cancer Prev Res (Phila); 2018 Aug; 11(8):491-502. PubMed ID: 29764807
[TBL] [Abstract][Full Text] [Related]
18. Prognostic markers in stage I oral cavity squamous cell carcinoma.
Dunkel J; Vaittinen S; Grénman R; Kinnunen I; Irjala H
Laryngoscope; 2013 Oct; 123(10):2435-41. PubMed ID: 23918741
[TBL] [Abstract][Full Text] [Related]
19. Serum exosome-derived biomarkers for the early detection of oral squamous cell carcinoma.
Guo H; Jiang W; Huang S; Huang X; Li C
Mol Cell Biochem; 2021 Dec; 476(12):4435-4447. PubMed ID: 34468926
[TBL] [Abstract][Full Text] [Related]
20. Tumor budding as a novel predictor of occult metastasis in cT2N0 tongue squamous cell carcinoma.
Sakata J; Yamana K; Yoshida R; Matsuoka Y; Kawahara K; Arita H; Nakashima H; Nagata M; Hirosue A; Kawaguchi S; Gohara S; Nagao Y; Hiraki A; Shinohara M; Toya R; Murakami R; Nakayama H
Hum Pathol; 2018 Jun; 76():1-8. PubMed ID: 29307623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
